Trial · NCT01011920
Adverse events390
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 390
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Coagulation disorders | Vascular disorders | Arm A / MTX + AraC | 9 | 75 | 16 |
| other | Coagulation disorders | Vascular disorders | Arm B / MTX + Ara-C + Rituximab | 11 | 69 | 18 |
| other | Coagulation disorders | Vascular disorders | Arm C / MTX + Ara-C + Rituximab+Thiotepa | 7 | 75 | 11 |
| other | Coagulation disorders | Vascular disorders | Arm D / WBRT 36 Gy +/- Boost 9 Gy | 5 | 55 | 5 |
| other | Coagulation disorders | Vascular disorders | Arm E / BCNU + Thiotepa + APBSCT | 7 | 58 | 7 |
| other | Neurological toxicity | Nervous system disorders | Arm A / MTX + AraC | 13 | 75 | 34 |
| other | Neurological toxicity | Nervous system disorders | Arm B / MTX + Ara-C + Rituximab | 18 | 69 | 38 |
| other | Neurological toxicity | Nervous system disorders | Arm C / MTX + Ara-C + Rituximab+Thiotepa | 13 | 75 | 27 |
| other | Neurological toxicity | Nervous system disorders | Arm D / WBRT 36 Gy +/- Boost 9 Gy | 10 | 55 | 10 |
| other | Neurological toxicity | Nervous system disorders | Arm E / BCNU + Thiotepa + APBSCT | 4 | 58 | 4 |
| other | Anaemia | Blood and lymphatic system disorders | Arm A / MTX + AraC | 66 | 75 | 187 |
| other | Anaemia | Blood and lymphatic system disorders | Arm B / MTX + Ara-C + Rituximab | 65 | 69 | 207 |
| other | Anaemia | Blood and lymphatic system disorders | Arm C / MTX + Ara-C + Rituximab+Thiotepa | 71 | 75 | 261 |
| other | Anaemia | Blood and lymphatic system disorders | Arm D / WBRT 36 Gy +/- Boost 9 Gy | 9 | 55 | 9 |
| other | Anaemia | Blood and lymphatic system disorders | Arm E / BCNU + Thiotepa + APBSCT | 40 | 58 | 40 |
| other | Neutropenia | Blood and lymphatic system disorders | Arm A / MTX + AraC | 68 | 75 | 129 |
| other | Neutropenia | Blood and lymphatic system disorders | Arm B / MTX + Ara-C + Rituximab | 65 | 69 | 158 |
| other | Neutropenia | Blood and lymphatic system disorders | Arm C / MTX + Ara-C + Rituximab+Thiotepa | 69 | 75 | 198 |
| other | Neutropenia | Blood and lymphatic system disorders | Arm D / WBRT 36 Gy +/- Boost 9 Gy | 7 | 55 | 7 |
| other | Neutropenia | Blood and lymphatic system disorders | Arm E / BCNU + Thiotepa + APBSCT | 49 | 58 | 58 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01011920/events